Literature DB >> 1658362

Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.

S A Lewis1, D O Morgan, M J Grubman.   

Abstract

Plasmids containing the foot-and-mouth disease virus structural protein precursor (P1) and 3C protease genes or the P1 gene alone were expressed in Escherichia coli. A recombinant baculovirus containing the P1 gene was also generated and expressed in Spodoptera frugiperda cells. Expression of the P1 and 3C genes in E. coli resulted in efficient synthesis and processing of the structural protein precursor and assembly into 70S empty capsids. This material reacted with neutralizing monoclonal antibodies which recognize only conformational epitopes and elicited a significant neutralizing antibody response in vaccinated guinea pigs. Expression of the P1 gene in E. coli resulted in synthesis of an insoluble product, whereas in insect cells infected with the recombinant baculovirus a soluble product was synthesized. Both soluble and insoluble P1 reacted with a 12S-specific monoclonal antibody, but only soluble P1 elicited a neutralizing antibody response in guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658362      PMCID: PMC250715     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Capsid protein VP4 of poliovirus is N-myristoylated.

Authors:  A V Paul; A Schultz; S E Pincus; S Oroszlan; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Myristylation of picornavirus capsid protein VP4 and its structural significance.

Authors:  M Chow; J F Newman; D Filman; J M Hogle; D J Rowlands; F Brown
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.

Authors:  H L Bachrach; D M Moore; P D McKercher; J Polatnick
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

5.  Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes.

Authors:  J C Saiz; M J Gonzalez; D O Morgan; J L Card; F Sobrino; D M Moore
Journal:  Virus Res       Date:  1989-05       Impact factor: 3.303

6.  T7 RNA polymerase can direct expression of influenza virus cap-binding protein (PB2) in Escherichia coli.

Authors:  A H Rosenberg; F W Studier
Journal:  Gene       Date:  1987       Impact factor: 3.688

7.  Characterization of a nonstructural phosphoprotein of two orbiviruses.

Authors:  M A Devaney; J Kendall; M J Grubman
Journal:  Virus Res       Date:  1988-09       Impact factor: 3.303

8.  Detection of foot-and-mouth disease virus by competitive ELISA using a monoclonal antibody specific for the 12S protein subunit from six of the seven serotypes.

Authors:  E N Smitsaart; J C Saiz; R J Yedloutschnig; D O Morgan
Journal:  Vet Immunol Immunopathol       Date:  1990-11       Impact factor: 2.046

9.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  26 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.

Authors:  C Tami; G Kaplan; M E Piccone; E L Palma
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 4.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

5.  Comparison of strategies for the production of FMDV empty capsids using the baculovirus vector system.

Authors:  V Ruiz; A C Mignaqui; M C Nuñez; E Reytor; J M Escribano; A Wigdorovitz
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

6.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines.

Authors:  Roberto Mateo; Eva Luna; Verónica Rincón; Mauricio G Mateu
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

8.  Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.

Authors:  Miguel Rodríguez Pulido; Francisco Sobrino; Belén Borrego; Margarita Sáiz
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus.

Authors:  L G Kleina; M J Grubman
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.